Free tool
FAERS Monitor: Acticlate
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 205931 or its brand name (Acticlate, Doxycycline Hyclate). Reports on generic versions are filed under their own applications.
Reports
17,438
Serious
10,245
59% of reports
Hospitalization
4,803
Death reported
2,363
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug hypersensitivity2,303
- fatigue1,817
- nausea1,709
- pain1,489
- rash1,462
- off label use1,431
- drug ineffective1,414
- headache1,402
- diarrhoea1,368
- dyspnoea1,348
- vomiting1,337
- pruritus1,165
- pneumonia1,157
- dizziness1,114
- condition aggravated1,094
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 15 |
| 2005 | 14 |
| 2006 | 23 |
| 2007 | 25 |
| 2008 | 36 |
| 2009 | 88 |
| 2010 | 107 |
| 2011 | 142 |
| 2012 | 255 |
| 2013 | 251 |
| 2014 | 341 |
| 2015 | 561 |
| 2016 | 1,057 |
| 2017 | 1,000 |
| 2018 | 1,393 |
| 2019 | 1,665 |
| 2020 | 1,507 |
| 2021 | 1,126 |
| 2022 | 1,186 |
| 2023 | 1,259 |
| 2024 | 1,874 |
| 2025 | 2,120 |
| 2026 | 1,392 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,036,721 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug hypersensitivitySignal | 2,303 | 14.5 | 14.0 | 28,888 |
| condition aggravatedSignal | 1,094 | 4.4 | 4.1 | 2,852 |
| pneumoniaSignal | 1,157 | 4.3 | 4.1 | 2,987 |
| rashSignal | 1,462 | 4.1 | 3.9 | 3,422 |
| pruritusSignal | 1,165 | 3.7 | 3.5 | 2,289 |
| vomitingSignal | 1,337 | 3.4 | 3.3 | 2,354 |
| painSignal | 1,489 | 2.9 | 2.8 | 1,941 |
| dyspnoeaSignal | 1,348 | 2.9 | 2.7 | 1,690 |
| fatigueSignal | 1,817 | 2.8 | 2.7 | 2,208 |
| headacheSignal | 1,402 | 2.7 | 2.6 | 1,543 |
| dizzinessSignal | 1,114 | 2.7 | 2.5 | 1,215 |
| nauseaSignal | 1,709 | 2.6 | 2.5 | 1,755 |
| diarrhoeaSignal | 1,368 | 2.6 | 2.4 | 1,337 |
| off label use | 1,431 | 2.0 | 1.9 | 714 |
| drug ineffective | 1,414 | 1.3 | 1.2 | 101 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.